HOME › DRUGS › NERATINIB
ACTIVE SUBSTANCE / INN

NERATINIB

Brand name(s): Nerlynx
EMA LISTED
AUTHORISED
Breast Neoplasms
ACTIVE SUBSTANCE
Neratinib
REGULATORS
EMA
SPONSORS / MAH
Pierre Fabre Medicament
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
NerlynxPierre Fabre MedicamentAuthorised31/08/2018Breast Neoplasms

FULL INTELLIGENCE ON NERATINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →